Abstract

We present a case of new-onset hyperthyroidism with autoimmune thyroid disease which developed four weeks after COVID-19 infection. The patient responded well to methimazole and beta blockers in combination. Three similar cases have been described and their clinical features and investigation results are compared with those in our case.